scholarly article | Q13442814 |
P50 | author | Ian Andrew Wilson | Q5983280 |
Jeffery W. Kelly | Q6175781 | ||
Karl Barry Sharpless | Q110925 | ||
Benjamin Cravatt | Q4888433 | ||
Stefano Forli | Q63385497 | ||
Hua Wang | Q63385706 | ||
Lars Plate | Q42410251 | ||
P2093 | author name string | David E Mortenson | |
Suhua Li | |||
Evan T Powers | |||
Wentao Chen | |||
Gabriel J Brighty | |||
Grant Bare | |||
P2860 | cites work | The Protein Data Bank | Q24515306 |
Comparison of apo- and heme-bound crystal structures of a truncated human heme oxygenase-2 | Q24621015 | ||
Modulation of intracellular ROS levels by TIGAR controls autophagy | Q24644257 | ||
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis | Q26764754 | ||
Identification, characterization, and crystal structure of the Omega class glutathione transferases | Q27622324 | ||
Rational design of an organometallic glutathione transferase inhibitor | Q27655297 | ||
On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases | Q27676208 | ||
The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution | Q27748324 | ||
Profiling the specific reactivity of the proteome with non-directed activity-based probes | Q28200208 | ||
A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes | Q28219495 | ||
Structure-function relationships of cellular retinoic acid-binding proteins. Quantitative analysis of the ligand binding properties of the wild-type proteins and site-directed mutants | Q28301476 | ||
Chemical Proteomic Profiling of Human Methyltransferases | Q28821490 | ||
Proteome-wide covalent ligand discovery in native biological systems | Q28829116 | ||
Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance | Q31030253 | ||
Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype | Q31090816 | ||
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities | Q33235638 | ||
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets | Q33649348 | ||
The resurgence of covalent drugs | Q34174891 | ||
The role of glutathione-S-transferase in anti-cancer drug resistance | Q34272162 | ||
Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis | Q34293667 | ||
The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease | Q43120812 | ||
Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition | Q44358246 | ||
Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition | Q44404296 | ||
Expression of nm23‐H1 is associated with poor prognosis in peripheral T‐cell lymphoma | Q44655400 | ||
Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. | Q46005837 | ||
On the nature of organic catalysis "on water". | Q46333766 | ||
Chemical proteomics with sulfonyl fluoride probes reveals selective labeling of functional tyrosines in glutathione transferases | Q46771140 | ||
Covalent Enzyme Inhibition through Fluorosulfate Modification of a Noncatalytic Serine Residue | Q48109970 | ||
Competition-based, quantitative chemical proteomics in breast cancer cells identifies new target profiles for sulforaphane | Q48237312 | ||
Beta-lactams as selective chemical probes for the in vivo labeling of bacterial enzymes involved in cell wall biosynthesis, antibiotic resistance, and virulence. | Q50777469 | ||
Selective Inhibitors of Glutathione Transferase P1 with Trioxane Structure as Anticancer Agents | Q59613491 | ||
Efficient and highly selective covalent labeling of the estrogen receptor with [3H]tamoxifen aziridine | Q71687809 | ||
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma | Q73549780 | ||
Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone | Q82948471 | ||
Sulfonyl fluoride analogues as activity-based probes for serine proteases | Q87371817 | ||
Ibrutinib (PCI-32765), the first BTK (Bruton's tyrosine kinase) inhibitor in clinical trials | Q34321304 | ||
Extreme electric fields power catalysis in the active site of ketosteroid isomerase | Q34454777 | ||
"On water": unique reactivity of organic compounds in aqueous suspension | Q34556981 | ||
Structural basis of perturbed pKa values of catalytic groups in enzyme active sites | Q34670783 | ||
Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags | Q34756963 | ||
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics | Q35491186 | ||
Chemical strategies for activity-based proteomics | Q35616321 | ||
Selective N-Hydroxyhydantoin Carbamate Inhibitors of Mammalian Serine Hydrolases | Q35676731 | ||
A fluorogenic aryl fluorosulfate for intraorganellar transthyretin imaging in living cells and in Caenorhabditis elegans | Q35756357 | ||
Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function | Q35838174 | ||
Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis. | Q36086478 | ||
Chemoproteomic profiling of host and pathogen enzymes active in cholera | Q36614194 | ||
Activity-based protein profiling: the serine hydrolases | Q36773877 | ||
N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5. | Q36881797 | ||
Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer | Q36934087 | ||
Retinoic acid in the development, regeneration and maintenance of the nervous system | Q36946560 | ||
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue | Q37008862 | ||
A coupled protein and probe engineering approach for selective inhibition and activity-based probe labeling of the caspases | Q37043619 | ||
Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis | Q37222633 | ||
Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition | Q37251595 | ||
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor | Q37329941 | ||
Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis. | Q37414141 | ||
A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles | Q37513287 | ||
Targeted covalent drugs of the kinase family | Q37770660 | ||
Current developments in activity-based protein profiling | Q38221616 | ||
The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression. | Q38239598 | ||
Covalent protein modification: the current landscape of residue-specific electrophiles | Q38280788 | ||
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies | Q38499073 | ||
Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas | Q38818624 | ||
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes. | Q39041277 | ||
Investigating the proteome reactivity and selectivity of aryl halides | Q39248781 | ||
Selective Covalent Protein Modification by 4-Halopyridines through Catalysis. | Q40226850 | ||
Serum nm23-H1 protein as a prognostic factor in hematological malignancies | Q40713872 | ||
A tyrosine-reactive irreversible inhibitor for glutathione S-transferase Pi (GSTP1). | Q41859046 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | drug discovery | Q1418791 |
P304 | page(s) | 200-210 | |
P577 | publication date | 2017-12-21 | |
P1433 | published in | Journal of the American Chemical Society | Q898902 |
P1476 | title | "Inverse Drug Discovery" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates | |
P478 | volume | 140 |
Q92757150 | A rapid access to aliphatic sulfonyl fluorides |
Q90665895 | Activity-Based Sensing: A Synthetic Methods Approach for Selective Molecular Imaging and Beyond |
Q90254510 | Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy |
Q64968466 | Arylfluorosulfate-Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal. |
Q93178340 | Biocompatible SuFEx Click Chemistry: Thionyl Tetrafluoride (SOF4 )-Derived Connective Hubs for Bioconjugation to DNA and Proteins |
Q83232453 | Ceapins block the unfolded protein response sensor ATF6α by inducing a neomorphic inter-organelle tether |
Q90402827 | Emerging Utility of Fluorosulfate Chemical Probes |
Q52619354 | Genetically Encoding Fluorosulfate-l-tyrosine To React with Lysine, Histidine, and Tyrosine via SuFEx in Proteins in Vivo. |
Q91452567 | Global targeting of functional tyrosines using sulfur-triazole exchange chemistry |
Q92997375 | Installation of -SO2F groups onto primary amides |
Q56530196 | Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins |
Q99728291 | Protein targeting with SAF(er) electrophiles |
Q90371179 | Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases |
Q98459819 | Stability and cell permeability of sulfonyl fluorides in the design of Lys-covalent antagonists of protein-protein interactions |
Q93105246 | SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase |
Q64027818 | Sulfonyl Fluorides (SFs): More Than Click Reagents? |
Q99637234 | Using sulfuramidimidoyl fluorides that undergo sulfur(VI) fluoride exchange for inverse drug discovery |
Search more.